NEW YORK (GenomeWeb News) – Foundation Medicine reported after the close of the market Tuesday that its fourth quarter revenues climbed 87 percent year over year and 18 percent over the previous quarter.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $9.7 million for the three months ended Dec. 31, up from $5.2 million in Q4 2012 and $8.2 million in Q3 2013. It beat the consensus Wall Street estimate of $9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.